1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alpha particle immunotherapy with bismuth-213-labeled anti-CD33 monoclonal antibody HuM195 in myeloid leukemia
    Meeting Abstract

    Jurcic, J. G.; Burke, J. M. ; McDevitt, M. R.; Divgi, C. R.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Abstracts of Papers of the American Chemical Society (2003)

    Fulltext@MSK | Save
  • Head-to-head comparison of epoetin alfa 40,000 U QW vs. darbepoetin alfa 200 mcg Q2W in anemic patients with cancer receiving chemotherapy: Preliminary results
    Meeting Abstract

    Jakubowski, A. A.; Hurria, A.; Williams, D.
    Blood (2003)

    Fulltext@MSK | Save
  • Follicular lymphoma grade 3 is not equivalent to follicular large cell lymphoma: Comparison of the WHO and IWF classification system
    Meeting Abstract

    Halaas, J. L.; Feldstein, J. T.; Zelenetz, A. D.
    Blood (2003)

    Fulltext@MSK | Save
  • CD52 expression in acute leukemia and advanced MDS: 118 cases at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Gupta, S.; Lamanna, N.; Rose, R.; Maslak, P. G.; Weiss, M. A.
    Blood (2003)

    Fulltext@MSK | Save
  • A phase II study of stem cell mobilization with IV melphalan (60 mg/M-2) + G-CSF in multiple myeloma
    Meeting Abstract

    Gupta, S.; Costello, S.; Zhou, P.; Reich, L.; Hassoun, H.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Fleisher, M.; Hedvat, C.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • The BEXXAR (R) therapeutic regimen (Tositumomab and iodine I 131 tositumomab) can be safely administered to patients over the age of 70
    Meeting Abstract

    Gregory, S. A.; Zelenetz, A. D.; Knox, S. J.; Vase, J. M.; Kaminski, M. S.
    Blood (2003)

    Fulltext@MSK | Save
  • Bexxar® (tositumomab and iodine I 131 tositumomab) is well tolerated and efficacious in heavily pretreated patients with non-Hodgkin's lymphoma (NHL) and mild thrombocytopenia
    Meeting Abstract

    Goldsmith, S. J.; Kostakoglu, L.; Wahl, R.; Alavi, A.; Divgi, C.; Hankins, J.; Zelenetz, A.; Kaminski, M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Newly defined epitopes for mouse tyrosinase demonstrate potent CD8+T-cell responses to xenogeneic immunization with tyrosinase
    Meeting Abstract

    Goldberg, S. M.; Guevara-Patiño, J. A.; Montgomery, S. C.; Perales, M. A.; Houghton, A. N.; Wolchok, J. D.
    Journal of Immunotherapy (2003)

    Fulltext@MSK | Save
  • Utilization of rituximab therapy in patients (pts) with newly diagnosed follicular (FL) and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in the United States: An analysis from the national comprehensive cancer network (NCCN) NHL outcomes project
    Meeting Abstract

    Friedberg, J. W.; Lepisto, E.; Rodriguez, M. A.; Ottensen, R.; LaCasce, A. S.; Nademanee, A. P.; Millenson, M.; Czuczman, M.; Niland, J.; Zelenetz, A. D.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • MUC-1 mucin positive patients with diffuse large B-cell lymphoma, a poor prognostic factor for outcome
    Meeting Abstract

    Feldstein, J. T.; Houldsworth, J.; Olshen, A.; Goy, A.; Donnelly, G.; Gilles, F.; Chaganti, R. S. K.; Zelenetz, A. D.
    Blood (2003)

    Fulltext@MSK | Save